Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 195
The New Cholesterol Management Guidelines
Lisa R. Tannock, MD
University of Kentucky, Lexington, Kentucky
from Clinical Endocrinology Update 2019 on September 5, 2019 11:25 AM-11:55 AM
Q&A/Panel Discussion
Scott Kahan, MD, MPH
National Center for Weight and Wellness, Washington, District of Columbia
Donna H. Ryan, MD
Pennington Biomedical Research Center, Baton Rouge, Louisiana
Lisa R. Tannock, MD
University of Kentucky, Lexington, Kentucky
Connie Baum Newman, MD
New York University, New York City, New York
Daniel H. Bessesen, MD
University of Colorado Health Sciences Center, Denver, Colorado
from Clinical Endocrinology Update 2019 on September 5, 2019 11:55 AM-12:10 PM
Challenging Cases in Lipid Management
Lisa R. Tannock, MD
University of Kentucky, Lexington, Kentucky
from Clinical Endocrinology Update 2019 on September 5, 2019 1:25 PM-2:10 PM
Is HDL a Risk Factor or Risk Marker? The Clinical Take-Home Message
Jay Heinecke, MD
University of Washington Medical Center, Seattle, WA
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
New Cholesterol Guidelines 2018
Neil J Stone, MD
Northwestern University, Chicago, IL
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
Cholesterol-Carrying Lipoproteins and CVD Risk
Anne Carol Goldberg, MD
Washington Univ School of Med, Saint Louis, MO
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
Chylomicronemia: Is It Due to Genes or Environment or Both, and What Is the Contribution of Glycemic Control?
Alan Chait, MBChB, MD
University of Washington, Seattle, WA
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Triglycerides and ASCVD in Patients with Diabetes and Insulin Resistance: Evidence Connecting Them and the Most Likely Mechanisms
Ira J Goldberg, MD
NYU Medical Center, New York, NY
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Moderate Hypertriglyceridemia: Should It Be Treated, and If So, How?
P. Barton Duell, MD
Oregon Health and Science University, Portland, OR
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Chair
Ira J Goldberg, M.D.
NYU Med Ctr, New York, NY
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
Shared Mechanisms Linking Sugar-Regulated Carbohydrate and Lipid Metabolism
Mark A Herman, MD
Duke Univ Med Ctr, Durham, NC
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
Regulation of Lipid and Glucose Metabolism by Bile Acids
Rebecca Haeusler, PhD
Columbia Univ, New York, NY
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
VLDL Production, Hypertriglyceridemia, and Risk of Vascular Disease
Henry N Ginsberg, MD
Columbia Univ Coll of Phys & S, New York, NY
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
Recently Arrived and Pipeline Drugs for Dyslipidemia
Anne Carol Goldberg, MD
Washington Univ School of Med, Saint Louis, MO
from ENDO 2018 on March 18, 2018 9:45 AM-10:30 AM
What Have We Learned from the Look AHEAD Trial?
Donna H. Ryan, MD
Pennington Biomed Research Center, New Orleans, LA
from Clinical Endocrinology Update 2017 on September 23, 2017 10:50 AM-11:20 AM
Key Controversies in Lipidology
Ira J. Goldberg, MD
NYU Medical Center, New York, NY
from Clinical Endocrinology Update 2017 on September 23, 2017 11:20 AM-11:50 AM
Q&A/Panel Discussion with Drs. Kushner, Ryan, and Goldberg
Robert F. Kushner, MD
Northwestern University Feinberg School of Medcine, Chicago, IL
Donna H. Ryan, MD
Pennington Biomed Research Center, New Orleans, LA
Ira J. Goldberg, MD
NYU Medical Center, New York, NY
from Clinical Endocrinology Update 2017 on September 23, 2017 11:50 AM-12:05 PM
Obesity/Lipids Board Review
Andrea D. Coviello, MD
Duke University, Durham, NC
from Endocrine Board Review 2017 on September 26, 2017 2:45 PM-4:30 PM
Adipose Tissue Plasticity and Cardiometabolic Risk
Michael Dennis Jensen, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Fat Catabolism in Cardiometabolic Disease: Friend or Foe?
Erin E Kershaw, MD
University of Pittsburgh, Pittsburgh, PA
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Adipose Tissue Dynamics in Metabolism
Steven R Smith, MD
Florida Hospital, Orlando, FL
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Lipodystrophy Syndromes
Abhimanyu Garg, MD
University of Texas SW Medical Center, Dallas, TX
from ENDO 2017 on April 1, 2017 2:30 PM-3:15 PM
Glomerular Lipids and the Kidney
Alessia Fornoni, MD, PhD
University of Miami, Miami, FL
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Novel Treatment Targets for Diabetic Kidney Disease
Robert C Stanton, MD
Joslin Diabetes Center, Boston, MA
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
The Metabolic Effects of Dysfunctional Fatty Acid Metabolism in Obesity
Amalia Gastaldelli, PHD
CNR, Inst of Clinical Physiology, Pisa, Italy
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 195